Aulos to begin Phase II portion of solid tumour therapy trial
Aulos Bioscience has unveiled plans to begin the Phase II portion of its Phase I/II clinical study of human IgG1…
Aulos Bioscience has unveiled plans to begin the Phase II portion of its Phase I/II clinical study of human IgG1…
MyMD Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application…
Alentis Therapeutics has dosed the first subject in a Phase II clinical study of its investigational monoclonal antibody, lixudebart, to…
280Bio has dosed the first subject in a Phase I clinical study of oral pan-RAS inhibitor, TEB-17231 (YL-17231), to treat…
SciNeuro Pharmaceuticals has concluded subject dosing in the Phase I clinical study of its oral therapeutic candidate, SNP318, to treat…
Neurogene has dosed the first two female paediatric subjects in Phase I/II trial of its investigational adeno-associated virus (AAV) gene…
Acadia Pharmaceuticals has commenced the pivotal Phase III study of carbetocin nasal spray (ACP-101) to treat hyperphagia in Prader-Willi syndrome…
Vaxxas has reported positive results from a Phase I clinical trial for the measles and rubella (MR) vaccine, which was…
SciSparc has commenced the clinical trial of its new therapy, SCI-210, to treat ASD symptoms in children. ASD differs widely…
Canadian pharmaceutical company Medicure has received full approval from the US Food and Drug Administration (FDA) to enrol subjects in…